Ex vivo liver resection for tumoral pathology – benefits, risks and outcomes

HIGHLIGHTS

  • who: Ref Ro Med J. et al. from the Davila" University of Medicine and Pharmacy have published the research work: Ex vivo liver resection for tumoral pathology - benefits, risks and outcomes, in the Journal: (JOURNAL) of 15/08/2019
  • what: This is a literature review of the largest studies conducted on the theme of ex vivo liver resection for tumoral pathology.

SUMMARY

    The patient's liver was explanted, maintained in a cardioplegic (histidinetryptophan-ketoglutarate) solution, the lesions were resected and the remnant liver parenchyma was implanted six hours later; during the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?